The Research and Development team at Nurix Therapeutics is dedicated to advancing the discovery and development of innovative small molecule drugs aimed at modulating protein levels for cancer treatment. This interdisciplinary team collaborates on preclinical pharmacology, discovery biology, medicinal chemistry, and bioanalytical chemistry to optimize drug candidates that leverage the body's immune response. Through rigorous scientific exploration, the team drives projects from early discovery through preclinical stages, ensuring the potential of novel immuno-oncology agents.
View all